<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04749290</url>
  </required_header>
  <id_info>
    <org_study_id>20-SM-09-Bunge-001</org_study_id>
    <nct_id>NCT04749290</nct_id>
  </id_info>
  <brief_title>Effects of an Infant Formula on Growth, Safety and Efficacy for Healthy Term Infants</brief_title>
  <official_title>Comparative Effects of Cow's Milk Based Infant Formula Containing Both OPO and CPP Versus Non-OPO Formula and Breast Feeding on Growth, Stool Consistency and Bone Strength: A Double-blinded, Randomized and Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bunge Loders Croklaan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shijiazhuang Junlebao Dairy Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sprim Advanced Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bunge Loders Croklaan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate that a Cow's Milk Based Infant Formula A2 Containing&#xD;
      Both OPO and CPP for healthy term infants supports age-appropriate growth. In this&#xD;
      randomized, controlled trial (RCT), healthy, term, formula-fed (FF) infants will be&#xD;
      randomized to one of two infant formulas: a standard, commercially-available infant formula&#xD;
      for term infants (CF) or the study formula for term infants (SF) for 16 weeks. A reference&#xD;
      group of human milk-fed infants will also be enrolled. The primary objective is to compare&#xD;
      the growth, tolerance, stool consistency and bone strength of infants randomized to the study&#xD;
      infant formula (SF) versus infants randomized to the standard commercial infant formula (CF).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, controlled, double-blind, study of healthy term formula fed (FF)&#xD;
      infants. FF infants will be randomized to receive either a study infant formula, formulated&#xD;
      for healthy term infants or a commercially available infant formula for healthy term infants.&#xD;
      Infants will consume the formula for a total of 16-weeks; infant growth, tolerance, stool&#xD;
      consistency and bone strength will be assessed throughout the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anthropometric parameters</measure>
    <time_frame>1month to 5 months</time_frame>
    <description>Achieved body length (cm) and rate of gain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometric parameters</measure>
    <time_frame>1month to 5 months</time_frame>
    <description>Achieved body weight (kg) and rate of gain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometric parameters</measure>
    <time_frame>1month to 5 months</time_frame>
    <description>Achieved head circumferences (cm) and rate of gain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool characteristics</measure>
    <time_frame>1 month to 5 months</time_frame>
    <description>Infant Stool Form Scale to measure stool consistency (Bekkali et al, 2009): 4-point scale as watery (A) soft (B) formed (C) or hard (D)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool characteristics</measure>
    <time_frame>1 month to 5 months</time_frame>
    <description>Infant Stool Form Scale to measure stool amount (Bekkali et al, 2009): 4-pont scale as smear (1), up to 25% (2), 25-50% (3) or &gt;50% (4)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool characteristics</measure>
    <time_frame>1 month to 5 months</time_frame>
    <description>Infant Stool Form Scale to measure stool color (Bellali et al, 2009): 6 categories as yellow (I), orange (II), green (III), brown (IV), meconium (V) or clay-colored (VI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastrointestinal tract discomfort</measure>
    <time_frame>1 month to 5 months</time_frame>
    <description>frequency of parents observed and documented GI tract discomfort</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone Speed Of Sound</measure>
    <time_frame>at 1 month and 5 months</time_frame>
    <description>Ultrasound Bone Densitometer (BMD-A3)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Formula intake and tolerance (24 hour dietary recall)</measure>
    <time_frame>2 months to 5 months</time_frame>
    <description>ml /day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medically-diagnosed adverse events collected throughout the study period</measure>
    <time_frame>1 month to 5 months</time_frame>
    <description>frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crying and sleep tracking (24 hours recall)</measure>
    <time_frame>2 months to 5 months</time_frame>
    <description>frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone Mineral Content/Density</measure>
    <time_frame>at 5 months</time_frame>
    <description>DEXA</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Infant Development</condition>
  <arm_group>
    <arm_group_label>Study Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a Cow's Milk Based Infant Formula Containing Both OPO and CPP for term infants (JunLeBao ZhiZhen)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available infant formula without OPO for term infants (JunLeBao LeChun)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Human Milk Reference Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Human milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study Formula</intervention_name>
    <description>Study infant formula for term infants containing OPO and CPP</description>
    <arm_group_label>Comparator Formula</arm_group_label>
    <arm_group_label>Study Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  30 days of age at randomization, inclusive (day of birth is considered day 0)&#xD;
&#xD;
          -  Exclusively formula-fed or partially bottle feeding with intake more than 650 ml /day&#xD;
             for at least 3 days prior to randomization&#xD;
&#xD;
          -  Exclusively breast fed for at least 7 days prior to randomization&#xD;
&#xD;
          -  Singleton birth&#xD;
&#xD;
          -  Gestational age of 37-42 weeks (36 weeks and six days is considered 36 weeks of&#xD;
             gestational age)&#xD;
&#xD;
          -  Birth weight of 2500g to 4000g&#xD;
&#xD;
          -  Signed informed consent obtained for infant's participation in the study&#xD;
&#xD;
          -  Parent or guardian of infant agrees not to enroll infant in another interventional&#xD;
             clinical research study while participating in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of underlying metabolic or chronic disease; congenital malformation; or any&#xD;
             other condition which, in the opinion of the Investigator, is likely to interfere&#xD;
             with: the ability of the infant to ingest food, the normal growth and development of&#xD;
             the infant, or the evaluation of the infant&#xD;
&#xD;
          -  Evidence of feeding difficulties or formula intolerance, such as vomiting or poor&#xD;
             intake, at time of randomization (at investigator discretion)&#xD;
&#xD;
          -  Weight at Visit 1 is &lt;95% of birth weight [(weight at Visit 1Ã·birth weight) x 100&#xD;
             &lt;95%]&#xD;
&#xD;
          -  Infant is immunocompromised (according to a doctor's diagnosis of immunodeficiency&#xD;
             such as Combined Immunodeficiencies, DiGeorge Syndrome, Wiskott-Aldrich Syndrome,&#xD;
             Severe Congenital Neutropenia and Secondary Immunodeficiencies linked to HIV&#xD;
             infection, Down Syndrome or others) and children with known head/brain disease/injury&#xD;
             such as Microcephaly, Macrocephaly or others&#xD;
&#xD;
          -  Participation in another clinical trial&#xD;
&#xD;
          -  Known or increased risk of cow's milk allergy and/ or lactose intolerance (i.e. one of&#xD;
             the biological parents and or siblings diagnosed with cow's milk allergy, asthma, hay&#xD;
             fever, etc.)&#xD;
&#xD;
          -  Having a mother suffering from diabetes during pregnancy&#xD;
&#xD;
          -  Use of antibiotics at the time of screening, or during the past two weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaoyang Shen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wiola Mi, PhD</last_name>
    <phone>86 021-80252065</phone>
    <email>wiola.mi@bunge.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>JiangNan Street Community Health Service Center, WuCheng District</name>
      <address>
        <city>Jinhua</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Zhu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>QiuBin Street Community Health Service Center, WuCheng District</name>
      <address>
        <city>Jinhua</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Zhu</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 30, 2021</study_first_submitted>
  <study_first_submitted_qc>February 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

